The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient experiences of diagnosis and treatment of invasive lobular carcinoma: A qualitative study from a prospective registry.
 
Astrid Quirarte
No Relationships to Disclose
 
Anna Vertido
No Relationships to Disclose
 
Sophia Zamudio-Haas
No Relationships to Disclose
 
Jo Chien
Consulting or Advisory Role - Genentech/Roche
Research Funding - Amgen (Inst); Merck (Inst); Olema Oncology (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Pending Patent Application for “COMBINATION INCLUDING A CPG-C TYPE OLIGONUCLEOTIDE AND A PD-1 ANTAGONIST FOR TREATING BREAST CANCER”
Travel, Accommodations, Expenses - Genentech/Roche
 
Rita Mukhtar
Research Funding - GE Healthcare
Patents, Royalties, Other Intellectual Property - Patent on the use of fibrin and silver microparticles to promote wound healing. (I)